Answer
Yes. The selected product is licensed for certain postmenopausal women at high fracture risk when other licensed osteoporosis medicines are unsuitable.
Sources for this answer
- Tibolone 2.5 mg Tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.